THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09

THE ARTHRITIS-ASSOCIATED HLA-B(star)27:05 FORMS MORE CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN HLA(star)B27:09

Dades bibliogràfiques
Autors principals:	Shaw, J, Hatano, H, Cauli, A, Giles, J, McHugh, K, Mathieu, A, Bowness, P, Kollnberger, S
Format:	Conference item
Publicat:	2013

Ítems similars

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
per: Giles, J, et al.
Publicat: (2010)

HLA-B*2709 FORMS LESS CELL SURFACE B27 DIMER AND FREE HEAVY CHAIN LIGANDS FOR KIR3DL2 AND LILRB2 IMMUNORECEPTORS THAN ARTHRITIS-ASSOCIATED HLA-B*2705
per: Shaw, J, et al.
Publicat: (2012)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
per: Wong-Baeza, I, et al.
Publicat: (2011)

The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
per: Cauli, A, et al.
Publicat: (2013)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
per: Kollnberger, S, et al.
Publicat: (2007)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
per: Kollnberger, S, et al.
Publicat: (2012)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
per: Hatano, H, et al.
Publicat: (2013)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
per: Ridley, A, et al.
Publicat: (2013)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
per: Kollnberger, S, et al.
Publicat: (2010)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
per: Rysnik, O, et al.
Publicat: (2012)

HLA-B27
per: Bowness, P
Publicat: (2015)

HLA-B-27 heavy chain homodimer formation and natural killer cell family interaction - comparison of two HLA-B-27 subtypes in vitro
per: Giles, J, et al.
Publicat: (2008)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
per: Kollnberger, S, et al.
Publicat: (2010)

HLA-B27 HEAVY CHAIN DIMER EXPRESSION IN SPONDYLOARTHRITIS
per: Rysnik, O, et al.
Publicat: (2012)

KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis.
per: Wong-Baeza, I, et al.
Publicat: (2013)

KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
per: Wong-Baeza, I, et al.
Publicat: (2013)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
per: Bowness, P, et al.
Publicat: (2003)

Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis
per: Hatano, H, et al.
Publicat: (2013)

Functional characterisation of HLA-B27 in autoimmunity
per: Kollnberger, S, et al.
Publicat: (2001)

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
per: Bowness, P, et al.
Publicat: (2011)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
per: McHugh, K, et al.
Publicat: (2014)

HLA-B27 FORMS HEAVY CHAIN HOMODIMERS IN VITRO AND IN VIVO THAT BIND TO CELLULAR RECEPTORS INCLUDING LILR AND KIR FAMILY MEMBERS
per: McHugh, K, et al.
Publicat: (2010)

Direct visualisation of HLA-B27 forms in cell lines and Spondyloarthropathy tissues
per: Rysnik, O, et al.
Publicat: (2013)

The biochemistry and immunology of non-canonical forms of HLA-B27
per: Shaw, J, et al.
Publicat: (2014)

The pathogenesis of spondyloarthritides - HLA-B-27 homodimer expression on human monocyte/macrophage cell lines
per: McHugh, K, et al.
Publicat: (2008)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
per: Bowness, P, et al.
Publicat: (2010)

Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.
per: Appel, H, et al.
Publicat: (2004)

The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
per: Appel, H, et al.
Publicat: (2004)

The role of HLA-B27 in spondyloarthritis.
per: Allen, R, et al.
Publicat: (1999)

Dimers are forever. Expression and recognition of abnormal HLA-B27 in spondylo arthritis
per: Bowness, P, et al.
Publicat: (2005)

Identification and characterisation of cell surface HLA-B27 homodimers
per: Bird, L, et al.
Publicat: (2002)

Factors determining the cell surface expression of a novel HLA-B27 epitope
per: McHugh, K, et al.
Publicat: (2010)

Jekyll and Hyde: the transformation of HLA-B27.
per: Edwards, J, et al.
Publicat: (2000)

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.
per: Osiris Marroquin Belaunzaran, et al.
Publicat: (2015-01-01)

Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
per: Kuon, W, et al.
Publicat: (2001)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
per: Kollnberger, S, et al.
Publicat: (2004)

The role of HLA-B27 in the pathogenesis of spondyloarthritis
per: McHugh, K
Publicat: (2011)

HLA class I typing by PCR: HLA-B27 and an African B27 subtype.
per: Hill, A, et al.
Publicat: (1991)

The role of HLA-B27 interactions with natural killer receptors in the pathogenesis of spondyloarthritis
per: Kollnberger, S, et al.
Publicat: (2007)